Sphingolipid metabolizing enzymes as novel therapeutic targets. [electronic resource]
Producer: 20081224Description: 487-522 p. digitalISSN:- 0306-0225
- Aldehyde-Lyases -- antagonists & inhibitors
- Anaphylaxis -- physiopathology
- Animals
- Apoptosis -- drug effects
- Atherosclerosis -- physiopathology
- Bacterial Infections -- physiopathology
- Ceramides -- antagonists & inhibitors
- Cyclooxygenase 2 -- metabolism
- Dendritic Cells -- physiology
- Drug Design
- Enzyme Inhibitors -- therapeutic use
- Humans
- Immunologic Factors -- pharmacology
- Leukocytes -- physiology
- Lysophospholipids -- antagonists & inhibitors
- Macrophages -- physiology
- Mast Cells -- physiology
- Neoplasms -- drug therapy
- Neovascularization, Pathologic -- drug therapy
- Phosphotransferases (Alcohol Group Acceptor) -- antagonists & inhibitors
- RNA, Small Interfering -- therapeutic use
- Sphingolipids -- metabolism
- Sphingomyelin Phosphodiesterase -- antagonists & inhibitors
- Sphingosine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.